FULC / Fulcrum Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Fulcrum Therapeutics, Inc.
US ˙ NasdaqGM ˙ US3596161097

Jumlah Saham Beredar 54,091,588 shares
Saham Orang Dalam33,804,692 shares
Kepemilikan oleh Orang Dalam62.50 %
Orang Dalam Sejati43
Skor Sentimen Orang Dalam

Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.

Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan akumulasi orang dalam tertinggi.

Skor Sentimen Petugas

Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.

Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.

Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan sentimen orang dalam tertinggi.

Metrik Utama Orang Dalam

Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.

Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).

Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)

0 ( )

2084 out of 11305

Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).

Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)

0.000 %( )

2074 out of 11224

Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.

Grafik Perdagangan Orang Dalam

Grafik berikut menunjukkan Fulcrum Therapeutics, Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.

Daftar Orang Dalam dan Metrik Profitabilitas

Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.

See our leaderboard of most profitable insider traders.

Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan
6 Dimensions Capital, L.P. 10% Owner - [10%] 559,821 559,821
Santiago Arroyo Chief Medical Officer - [O] 0 0
Sonja Banks Director - [D] 0 0
Diego Cadavid SVP Clinical Development - [O] 65,714 65,714
Casdin Capital, LLC 10% Owner - [10%] 604,285 604,285
Eli Casdin 10% Owner - [10%] 604,285 604,285
Casdin Partners GP, LLC 10% Owner - [10%] 604,285 604,285
Casdin Partners Master Fund, L.P. 10% Owner - [10%] 604,285 604,285
Collins James J. Director - [D] 47,142 47,142
Katina Dorton Director - [D] 0 0
Judith Dunn See Remarks - [O] 0 0
Alan Ezekowitz Director - [D] 57,854 57,854
James A Geraghty Director - [D] 90,714 90,714
Plc Glaxosmithkline 10% Owner - [10%] 1,785,714 1,785,714
Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan
Robert J Gould Interim President & CEO, Director - [D] [O] 499,864 499,864
Kate Haviland 9,285
Hayes Melvin H. III Chief Operating Officer - [O] 0 0
Colin Hill Director - [D] 0 0
Patrick Taylor Horn Chief Medical Officer - [O] 0 0
Mark J Levin Director, 10% Owner - [D] [10%] 3,962,202 3,962,202
William J Maris 10% Owner - [10%] 464,285 464,285
Christopher Morabito Chief Medical Officer - [O] 1,100 1,100
Christopher Moxham Chief Scientific Officer - [O] 0 0
Alan A Musso Chief Financial Officer - [O] 0 0
Curtis Gale Oltmans SVP, General Counsel - [O] 1,248 1,248
Ra Capital Management, Llc 10% Owner - [10%] 20,458,198 20,458,198
Esther Rajavelu Chief Financial Officer - [O] 0 0
Kevin P Starr 10% Owner - [10%] 3,962,202 3,962,202
Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan
Sanofi 10% Owner - [10%] 558,035 558,035
Alex Sapir See Remarks, Director - [D] [O] 193,360 193,360
Section 32 Fund 2, LP 10% Owner - [10%] 464,285 464,285
Section 32 GP 2, LLC 10% Owner - [10%] 464,285 464,285
Bryan Stuart See Remarks, Director - [D] [O] 0 0
Robert I Tepper 10% Owner - [10%] 3,962,202 1,962,202
Trv Gp Iii, Llc 10% Owner - [10%] 3,962,202 1,962,202
Trv Gp Iv, Llc 10% Owner - [10%] 2,343,154 2,343,154
Third Rock Ventures GP III, L.P. 10% Owner - [10%] 3,962,202 1,962,202
Third Rock Ventures GP IV, L.P. 10% Owner - [10%] 2,343,154 2,343,154
Third Rock Ventures III, L.P. 10% Owner - [10%] 1,962,202 1,962,202
Third Rock Ventures IV, L.P. 10% Owner - [10%] 2,343,154 2,343,154
Thomson Peter G. VP Finance & Accounting - [O] 2,300 2,300
Greg Tourangeau Principal Accounting Officer - [O] 14,062 14,062
Wallace Owen B. Chief Scientific Officer - [O] 133,438 133,438

Report errors via our new Insider Auditing Tool

Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di FULC / Fulcrum Therapeutics, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2024-03-04 Sapir Alex 43,360 11.3475 43,360 11.3475 492,028 2 12.0000 28,293 5.75
2023-01-20 RA CAPITAL MANAGEMENT, LLC 1,923,076 13.0000 1,923,076 13.0000 24,999,988
2023-01-04 RA CAPITAL MANAGEMENT, LLC 122,334 7.0276 122,334 7.0276 859,714
2023-01-04 RA CAPITAL MANAGEMENT, LLC 58,369 7.7968 58,369 7.7968 455,091
2022-12-27 RA CAPITAL MANAGEMENT, LLC 4,089 5.9941 4,089 5.9941 24,510
2022-12-19 RA CAPITAL MANAGEMENT, LLC 98,787 5.8997 98,787 5.8997 582,814
2022-12-16 RA CAPITAL MANAGEMENT, LLC 1,341,420 5.4195 1,341,420 5.4195 7,269,826
2022-12-15 RA CAPITAL MANAGEMENT, LLC 237,029 5.4950 237,029 5.4950 1,302,474
2022-12-14 RA CAPITAL MANAGEMENT, LLC 824,600 5.4591 824,600 5.4591 4,501,574

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

FULC / Fulcrum Therapeutics, Inc. Insider Trades
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek

Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di FULC / Fulcrum Therapeutics, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2025-05-08 Tourangeau Greg 498 5.0600 498 5.0600 2,520 1 5.3700 155 6.16
2024-05-07 Tourangeau Greg 236 7.7600 236 7.7600 1,831
2024-03-08 Tourangeau Greg 4,884 11.7155 4,884 11.7155 57,219
2023-05-10 Tourangeau Greg 210 3.3100 210 3.3100 695

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

FULC / Fulcrum Therapeutics, Inc. Insider Trades
Riwayat Transaksi

Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.

Berkas
Tanggal
Perdagangan
Tanggal
Formulir Orang Dalam Ticker Judul Keamanan Kode 10b5-1 Langsung Latihan
Harga
Satuan
Harga
Unit
Diubah
Nilai
Diubah (1 ribu)
Sisa
Pilihan
Sisa
Saham
2025-05-09 2025-05-08 4 Tourangeau Greg FULC Common Stock S - Sale D 5.0600 -498 -3 14,062
2024-09-23 3 RA CAPITAL MANAGEMENT, LLC See footnotes FULC Common Stock I 10,229,099
2024-08-23 2024-08-21 4 RA CAPITAL MANAGEMENT, LLC See footnotes FULC Common Stock J - Other I -8,500,000 3,109,704
2024-07-08 2024-07-03 4 Sapir Alex FULC Common Stock M - Exercise D 3.2700 150,000 490 193,360
2024-06-18 3 Hill Colin FULC No securities are beneficially owned D 0
2024-05-09 2024-05-07 4 Tourangeau Greg FULC Common Stock S - Sale D 7.7600 -236 -2 11,571
2024-03-20 3 Horn Patrick Taylor FULC No securities are beneficially owned D 0
2024-03-08 2024-03-08 4 Tourangeau Greg FULC Common Stock S - Sale D 11.7155 -4,884 -57 11,807
2024-03-05 2024-03-04 4 Sapir Alex FULC Common Stock P - Purchase D 11.3475 43,360 492 43,360
2023-08-09 3 Musso Alan A FULC No securities are beneficially owned D 0
2023-05-11 2023-05-10 4 Tourangeau Greg FULC Common Stock S - Sale D 3.3100 -210 -1 15,992
2023-01-24 2023-01-20 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 13.0000 1,923,076 25,000 11,609,704
2023-01-13 2023-01-13 4 Gould Robert J FULC Common Stock S - Sale D 15.0000 -6,766 -101 499,864
2023-01-06 2023-01-04 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 7.7968 58,369 455 9,686,628
2023-01-06 2023-01-04 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 7.0276 122,334 860 9,628,259
2022-12-29 2022-12-27 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 5.9941 4,089 25 9,505,925
2022-12-21 2022-12-19 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 5.8997 98,787 583 9,501,836
2022-12-16 2022-12-16 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 5.4195 1,341,420 7,270 9,403,049
2022-12-16 2022-12-15 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 5.4950 237,029 1,302 8,061,629
2022-12-16 2022-12-14 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 5.4591 824,600 4,502 7,824,600
2022-12-15 2022-12-13 4 Third Rock Ventures III, L.P. FULC Common Stock J - Other D -2,000,000 1,962,202
2022-11-09 3 Arroyo Santiago FULC No securities are beneficially owned D 0
2022-08-26 3 Shah Rajeev M. FULC Common Stock I 7,000,000
2022-08-11 3 Hayes Melvin H. III FULC No securities are beneficially owned D 0
2022-06-08 2022-06-07 4 Gould Robert J FULC Common Stock S - Sale D 8.0898 -71,435 -578 506,630
2022-06-08 2022-06-07 4 Gould Robert J FULC Common Stock M - Exercise D 7.8400 71,435 560 578,065
2022-06-06 2022-06-06 4 Gould Robert J FULC Common Stock S - Sale D 8.1040 -24,382 -198 506,630
2022-06-06 2022-06-06 4 Gould Robert J FULC Common Stock M - Exercise D 7.8400 24,382 191 531,012
2022-06-06 2022-06-03 4 Gould Robert J FULC Common Stock S - Sale D 7.9471 -25,551 -203 506,630
2022-06-06 2022-06-03 4 Gould Robert J FULC Common Stock M - Exercise D 7.8400 25,551 200 532,181
2022-06-06 2022-06-02 4 Gould Robert J FULC Common Stock S - Sale D 7.9191 -16,689 -132 506,630
2022-06-06 2022-06-02 4 Gould Robert J FULC Common Stock M - Exercise D 7.8400 16,689 131 523,319
2022-05-10 2022-05-06 4 Tourangeau Greg FULC Stock Option (right to buy) A - Award D 8.63 6,500 6,500
2022-05-10 2022-05-06 4 Tourangeau Greg FULC Common Stock A - Award D 3,250 16,202
2022-04-11 2022-04-07 4 Gould Robert J FULC Stock Option (right to buy) M - Exercise D 7.84 -5,631 224,580
2022-04-11 2022-04-07 4 Gould Robert J FULC Common Stock S - Sale D 24.0150 -5,631 -135 506,630
2022-04-11 2022-04-07 4 Gould Robert J FULC Common Stock M - Exercise D 7.8400 5,631 44 512,261
2022-04-05 2022-04-05 4 Gould Robert J FULC Stock Option (right to buy) M - Exercise D 7.84 -52,552 230,211
2022-04-05 2022-04-05 4 Gould Robert J FULC Common Stock S - Sale D 24.2574 -52,552 -1,275 506,630
2022-04-05 2022-04-05 4 Gould Robert J FULC Common Stock M - Exercise D 7.8400 52,552 412 559,182
2022-04-05 2022-04-04 4 Gould Robert J FULC Stock Option (right to buy) M - Exercise D 7.84 -7,235 282,763
2022-04-05 2022-04-04 4 Gould Robert J FULC Common Stock S - Sale D 24.0151 -7,235 -174 506,630
2022-04-05 2022-04-04 4 Gould Robert J FULC Common Stock M - Exercise D 7.8400 7,235 57 513,865
2022-04-05 2022-04-01 4 Gould Robert J FULC Stock Option (right to buy) M - Exercise D 7.84 -34,464 289,998
2022-04-05 2022-04-01 4 Gould Robert J FULC Common Stock S - Sale D 24.0297 -34,464 -828 506,630
2022-04-05 2022-04-01 4 Gould Robert J FULC Common Stock M - Exercise D 7.8400 34,464 270 541,094
2022-03-14 3 Tourangeau Greg FULC Common Stock D 12,952
2022-01-21 2022-01-19 4 Morabito Christopher FULC Stock Option (right to buy) A - Award D 12.69 59,744 59,744
2022-01-21 2022-01-19 4 Oltmans Curtis Gale FULC Stock Option (right to buy) A - Award D 12.69 60,000 60,000
2022-01-21 2022-01-19 4 Dunn Judith FULC Stock Option (right to buy) A - Award D 12.69 140,890 140,890
2022-01-21 2022-01-19 4 Stuart Bryan FULC Stock Option (right to buy) A - Award D 12.69 340,000 340,000
2022-01-21 2022-01-19 4 Thomson Peter G. FULC Stock Option (right to buy) A - Award D 12.69 40,000 40,000
2022-01-10 2022-01-03 4 Rajavelu Esther FULC Stock Option (right to buy) A - Award D 17.82 200,000 200,000
2022-01-10 3 Rajavelu Esther FULC No securities are beneficially owned D 0
2022-01-07 2021-12-17 5 Oltmans Curtis Gale FULC Common Stock G - Gift D -1,088 1,248
2021-12-09 2021-12-08 4 Banks Sonja FULC Stock Option (right to buy) A - Award D 15.73 30,000 30,000
2021-12-09 3 Banks Sonja FULC No securities are beneficially owned D 0
2021-11-12 2021-11-10 4 LEVIN MARK J FULC Common Stock J - Other I -1,000,000 3,962,202
2021-11-12 2021-11-10 4 Third Rock Ventures III, L.P. FULC Common Stock J - Other D -1,000,000 3,962,202
2021-09-24 2021-09-22 4 Third Rock Ventures III, L.P. FULC Common Stock J - Other D -1,000,000 4,962,202
2021-09-24 2021-09-22 4 LEVIN MARK J FULC Common Stock J - Other I -1,000,000 4,962,202
2021-08-12 2021-08-11 4 Stuart Bryan FULC Stock Option (right to buy) M - Exercise D 7.84 -28,000 243,571
2021-08-12 2021-08-11 4 Stuart Bryan FULC Common Stock S - Sale D 23.7500 -28,000 -665 0
2021-08-12 2021-08-11 4 Stuart Bryan FULC Common Stock M - Exercise D 7.8400 28,000 220 28,000
2021-08-12 2021-08-10 4 Stuart Bryan FULC Stock Option (right to buy) M - Exercise D 7.84 -32,000 271,571
2021-08-12 2021-08-10 4 Stuart Bryan FULC Common Stock S - Sale D 17.5000 -32,000 -560 0
2021-08-12 2021-08-10 4 Stuart Bryan FULC Common Stock M - Exercise D 7.8400 32,000 251 32,000
2021-08-12 2021-08-10 4 Moxham Christopher FULC Stock Option (right to buy) M - Exercise D 7.84 -31,071 72,501
2021-08-12 2021-08-10 4 Moxham Christopher FULC Stock Option (right to buy) M - Exercise D 7.84 -20,714 103,572
2021-08-12 2021-08-10 4 Moxham Christopher FULC Common Stockm S - Sale D 18.0000 -31,071 -559 0
2021-08-12 2021-08-10 4 Moxham Christopher FULC Common Stock M - Exercise D 7.8400 31,071 244 31,071
2021-08-12 2021-08-10 4 Moxham Christopher FULC Common Stock S - Sale D 17.0000 -20,714 -352 0
2021-08-12 2021-08-10 4 Moxham Christopher FULC Common Stock M - Exercise D 7.8400 20,714 162 20,714
2021-06-29 2021-06-28 4 Thomson Peter G. FULC Common Stock P - Purchase I 9.0000 2,300 21 2,300
2021-06-29 2021-06-28 4 Oltmans Curtis Gale FULC Common Stock P - Purchase D 9.0100 1,088 10 1,088
2021-06-29 2021-06-28 4 Morabito Christopher FULC Common Stock P - Purchase D 9.1600 1,100 10 1,100
2021-06-29 2021-06-28 4 GERAGHTY JAMES A FULC Common Stock P - Purchase D 9.1600 10,000 92 90,714
2021-06-11 2021-06-09 4 Collins James J. FULC Stock Option (right to buy) A - Award D 8.85 15,000 15,000
2021-06-11 2021-06-09 4 GERAGHTY JAMES A FULC Stock Option (right to buy) A - Award D 8.85 15,000 15,000
2021-06-11 2021-06-09 4 LEVIN MARK J FULC Stock Option (right to buy) A - Award D 8.85 15,000 15,000
2021-06-11 2021-06-09 4 Ezekowitz Alan FULC Stock Option (right to buy) A - Award D 8.85 15,000 15,000
2021-06-11 2021-06-09 4 Dorton Katina FULC Stock Option (right to buy) A - Award D 8.85 15,000 15,000
2021-06-11 2021-06-09 4 Haviland Kate FULC Stock Option (right to buy) A - Award D 8.85 15,000 15,000
2021-05-12 2021-05-10 4 Morabito Christopher FULC Stock Option (right to buy) A - Award D 10.01 163,000 163,000
2021-05-12 3 Morabito Christopher FULC No securities are beneficially owned D 0
2021-04-02 2021-04-01 4 Dunn Judith FULC Stock Option (right to buy) A - Award D 12.00 215,000 215,000
2021-04-02 2021-03-31 4 Stuart Bryan FULC Stock Option (right to buy) A - Award D 11.78 350,000 350,000
2021-04-02 3 Dunn Judith FULC No securities are beneficially owned D 0
2021-03-17 2021-03-16 4 Gould Robert J FULC Common Stock S - Sale D 12.4279 -789 -10 506,630
2021-03-17 2021-03-15 4 Gould Robert J FULC Common Stock S - Sale D 12.1347 -9,211 -112 507,419
2021-02-24 2021-02-22 4 Thomson Peter G. FULC Stock Option (right to buy) M - Exercise D 7.84 -5,000 50,471
2021-02-24 2021-02-22 4 Thomson Peter G. FULC Common Stock S - Sale D 14.7163 -5,000 -74 15,212
2021-02-24 2021-02-22 4 Thomson Peter G. FULC Common Stock M - Exercise D 7.8400 5,000 39 20,212
2021-02-18 2021-02-16 4 Gould Robert J FULC Common Stock S - Sale D 14.5649 -1,673 -24 516,630
2021-02-18 2021-02-16 4 Gould Robert J FULC Common Stock S - Sale D 14.1899 -6,542 -93 518,303
2021-02-10 2021-02-08 4 Moxham Christopher FULC Stock Option (right to buy) A - Award D 12.60 100,000 100,000
2021-02-10 3 Moxham Christopher FULC No securities are beneficially owned D 0
2021-02-04 2021-02-02 4 Gould Robert J FULC Stock Option (right to buy) A - Award D 11.33 269,390 269,390
2021-01-27 2021-01-25 4 Thomson Peter G. FULC Stock Option (right to buy) A - Award D 13.09 40,000 40,000
2021-01-27 2021-01-25 4 Stuart Bryan FULC Stock Option (right to buy) A - Award D 13.09 134,376 134,376
2021-01-25 2021-01-21 4 Thomson Peter G. FULC Common Stock S - Sale D 14.0000 -6,607 -92 15,212
2021-01-22 2021-01-20 4 Gould Robert J FULC Common Stock S - Sale D 12.0826 -10,000 -121 524,845
2020-12-07 2020-12-03 4 Oltmans Curtis Gale FULC Stock Option (right to buy) A - Award D 11.82 153,600 153,600
2020-12-07 2020-12-03 4 Ezekowitz Alan FULC Stock Option (right to buy) A - Award D 11.82 15,000 15,000
2020-12-07 3 Oltmans Curtis Gale FULC No securities are beneficially owned D 0
2020-09-14 2020-09-14 4 Wallace Owen B. FULC Stock Option (right to buy) M - Exercise D 7.84 -6,350 75,592
2020-09-14 2020-09-14 4 Wallace Owen B. FULC Common Stock M - Exercise D 7.8400 6,350 50 133,438
2020-07-09 2020-07-08 4 Wallace Owen B. FULC Stock Option (right to buy) M - Exercise D 7.84 -2,951 81,942
2020-07-09 2020-07-08 4 Wallace Owen B. FULC Common Stock S - Sale D 20.0000 -2,951 -59 127,088
2020-07-09 2020-07-08 4 Wallace Owen B. FULC Common Stock M - Exercise D 7.8400 2,951 23 130,039
2020-07-09 2020-07-08 4 Gould Robert J FULC Common Stock S - Sale D 20.0000 -2,500 -50 534,845
2020-07-02 2020-07-01 4 Cadavid Diego FULC Common Stock S - Sale D 18.3000 -1,071 -20 65,714
2020-07-01 2020-06-30 4 Wallace Owen B. FULC Stock Option (right to buy) M - Exercise D 7.84 -141 84,893
2020-07-01 2020-06-30 4 Wallace Owen B. FULC Common Stock S - Sale D 20.0000 -141 -3 127,088
2020-07-01 2020-06-30 4 Wallace Owen B. FULC Common Stock M - Exercise D 7.8400 141 1 127,229
2020-06-26 2020-06-25 4 Gould Robert J FULC Common Stock S - Sale D 20.7968 -2,500 -52 537,345
2020-06-26 2020-06-25 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4.83 -1,459 12,277
2020-06-26 2020-06-25 4 Cadavid Diego FULC Common Stock S - Sale D 22.0000 -1,459 -32 66,785
2020-06-26 2020-06-25 4 Cadavid Diego FULC Common Stock M - Exercise D 4.8300 1,459 7 68,244
2020-06-15 2020-06-11 4 Haviland Kate FULC Stock Option (right to buy) A - Award D 17.63 9,285 9,285
2020-06-15 2020-06-11 4 Collins James J. FULC Stock Option (right to buy) A - Award D 17.63 9,285 9,285
2020-06-15 2020-06-11 4 Ezekowitz Alan FULC Stock Option (right to buy) A - Award D 17.63 9,285 9,285
2020-06-15 2020-06-11 4 GERAGHTY JAMES A FULC Stock Option (right to buy) A - Award D 17.63 9,285 9,285
2020-06-15 2020-06-11 4 LEVIN MARK J FULC Stock Option (right to buy) A - Award D 17.63 9,285 9,285
2020-06-12 2020-06-10 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4.83 -401 13,736
2020-06-12 2020-06-10 4 Cadavid Diego FULC Common Stock S - Sale D 22.0000 -401 -9 66,785
2020-06-12 2020-06-10 4 Cadavid Diego FULC Common Stock M - Exercise D 4.8300 401 2 67,186
2020-06-10 2020-06-09 4 Gould Robert J FULC Common Stock S - Sale D 20.0000 -156 -3 539,845
2020-06-09 2020-06-05 4 Gould Robert J FULC Common Stock S - Sale D 20.1722 -3,433 -69 540,001
2020-06-08 2020-06-05 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4.83 -451 14,137
2020-06-08 2020-06-05 4 Cadavid Diego FULC Common Stock S - Sale D 20.1791 -451 -9 66,785
2020-06-08 2020-06-05 4 Cadavid Diego FULC Common Stock M - Exercise D 4.8300 451 2 67,236
2020-06-08 2020-06-04 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4.83 -226 14,588
2020-06-08 2020-06-04 4 Cadavid Diego FULC Common Stock S - Sale D 20.0498 -226 -5 66,785
2020-06-08 2020-06-04 4 Cadavid Diego FULC Common Stock M - Exercise D 4.8300 226 1 67,011
2020-06-05 2020-06-04 4 Gould Robert J FULC Common Stock S - Sale D 20.0446 -1,300 -26 543,434
2020-06-05 2020-06-03 4 Gould Robert J FULC Common Stock S - Sale D 20.1283 -1,500 -30 544,734
2020-06-04 2020-06-03 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4.83 -338 14,814
2020-06-04 2020-06-03 4 Cadavid Diego FULC Common Stock S - Sale D 20.1763 -338 -7 66,785
2020-06-04 2020-06-03 4 Cadavid Diego FULC Common Stock M - Exercise D 4.8300 338 2 67,123
2020-06-04 2020-06-02 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4.83 -45 15,152
2020-06-04 2020-06-02 4 Cadavid Diego FULC Common Stock S - Sale D 20.0000 -45 -1 66,785
2020-06-04 2020-06-02 4 Cadavid Diego FULC Common Stock M - Exercise D 4.8300 45 0 66,830
2020-06-03 2020-06-02 4 Gould Robert J FULC Common Stock S - Sale D 20.0000 -2,797 -56 546,234
2020-06-03 2020-06-01 4 Gould Robert J FULC Common Stock S - Sale D 20.0000 -5 -0 549,031
2020-06-01 2020-05-29 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4.83 -200 15,197
2020-06-01 2020-05-29 4 Cadavid Diego FULC Common Stock S - Sale D 20.0350 -200 -4 66,785
2020-06-01 2020-05-29 4 Cadavid Diego FULC Common Stock M - Exercise D 4.8300 200 1 66,985
2020-06-01 2020-05-28 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4.83 -600 15,397
2020-06-01 2020-05-28 4 Cadavid Diego FULC Common Stock S - Sale D 20.0000 -600 -12 66,785
2020-06-01 2020-05-28 4 Cadavid Diego FULC Common Stock M - Exercise D 4.8300 600 3 67,385
2020-06-01 2020-05-28 4 Wallace Owen B. FULC Stock Option (right to buy) M - Exercise D 7.84 -2,232 85,034
2020-06-01 2020-05-28 4 Wallace Owen B. FULC Common Stock S - Sale D 20.0000 -2,232 -45 127,088
2020-06-01 2020-05-28 4 Wallace Owen B. FULC Common Stock M - Exercise D 7.8400 2,232 17 129,320
2020-06-01 2020-05-29 4 Gould Robert J FULC Common Stock S - Sale D 20.0797 -1,390 -28 549,036
2020-06-01 2020-05-28 4 Gould Robert J FULC Common Stock S - Sale D 20.0058 -1,919 -38 550,426
2020-05-29 2020-05-27 4 Wallace Owen B. FULC Stock Option (right to buy) M - Exercise D 7.84 -448 87,266
2020-05-29 2020-05-27 4 Wallace Owen B. FULC Common Stock S - Sale D 20.0000 -448 -9 127,088
2020-05-29 2020-05-27 4 Wallace Owen B. FULC Common Stock M - Exercise D 7.8400 448 4 127,536
2020-05-28 2020-05-26 4 Gould Robert J FULC Common Stock S - Sale D 20.0000 -2,500 -50 552,345
2020-05-28 2020-05-26 4 Wallace Owen B. FULC Stock Option (right to buy) M - Exercise D 7.84 -412 87,714
2020-05-28 2020-05-26 4 Wallace Owen B. FULC Common Stock S - Sale D 20.0000 -412 -8 127,088
2020-05-28 2020-05-26 4 Wallace Owen B. FULC Common Stock M - Exercise D 7.8400 412 3 127,500
2020-05-12 2020-05-11 4 Thomson Peter G. FULC Common Stock S - Sale D 16.0000 -7,500 -120 21,071
2020-05-12 2020-05-12 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4.83 -1,860 15,997
2020-05-12 2020-05-12 4 Cadavid Diego FULC Common Stock S - Sale D 18.0000 -1,860 -33 66,785
2020-05-12 2020-05-12 4 Cadavid Diego FULC Common Stock M - Exercise D 4.8300 1,860 9 68,645
2020-03-02 2020-03-02 4 Cadavid Diego FULC Common Stock S - Sale D 18.1255 -315 -6 66,785
2020-03-02 2020-03-02 4 Cadavid Diego FULC Common Stock S - Sale D 17.2567 -1,828 -32 67,100
2020-02-26 2020-02-24 4 Thomson Peter G. FULC Common Stock S - Sale D 18.6120 -250 -5 28,571
2020-02-26 2020-02-24 4 Thomson Peter G. FULC Common Stock S - Sale D 17.4326 -2,102 -37 28,821
2020-02-26 2020-02-24 4 Thomson Peter G. FULC Common Stock S - Sale D 16.1845 -2,648 -43 30,923
2020-02-20 2020-02-19 4 Wallace Owen B. FULC Stock Option (right to buy) M - Exercise D 7.84 -6,088 88,126
2020-02-20 2020-02-19 4 Wallace Owen B. FULC Common Stock S - Sale D 20.0000 -6,088 -122 127,088
2020-02-20 2020-02-19 4 Wallace Owen B. FULC Common Stock M - Exercise D 7.8400 6,088 48 133,176
2020-02-20 2020-02-19 4 Gould Robert J FULC Common Stock S - Sale D 20.0000 -2,500 -50 554,845
2020-02-05 2020-02-03 4 Cadavid Diego FULC Common Stock S - Sale D 17.3317 -2,143 -37 68,928
2020-01-27 2020-01-23 4 Wallace Owen B. FULC Stock Option (right to buy) A - Award D 16.87 58,900 58,900
2020-01-27 2020-01-23 4 Gould Robert J FULC Stock Option (right to buy) A - Award D 16.87 200,000 200,000
2020-01-27 2020-01-23 4 Thomson Peter G. FULC Stock Option (right to buy) A - Award D 16.87 33,100 33,100
2020-01-27 2020-01-23 4 Thomson Peter G. FULC Common Stock S - Sale D 18.0539 -262 -5 33,571
2020-01-27 2020-01-23 4 Thomson Peter G. FULC Common Stock S - Sale D 17.1743 -4,738 -81 33,833
2020-01-27 2020-01-23 4 Cadavid Diego FULC Stock Option (right to buy) A - Award D 16.87 55,440 55,440
2020-01-27 2020-01-23 4 Stuart Bryan FULC Stock Option (right to buy) A - Award D 16.87 105,000 105,000
2020-01-06 3 Dorton Katina FULC No securities are beneficially owned D 0
2020-01-06 2020-01-02 4 Dorton Katina FULC Stock Option (right to buy) A - Award D 15.86 18,571 18,571
2019-07-24 2019-07-22 4 GLAXOSMITHKLINE PLC FULC Series B Preferred Stock C - Conversion I -12,500,000 0
2019-07-24 2019-07-22 4 GLAXOSMITHKLINE PLC FULC Common Stock C - Conversion I 1,785,714 1,785,714
2019-07-23 2019-07-22 4 Sanofi Through its wholly-owned subsidiary, Aventis Inc. FULC Series B Preferred Stock (par value $0.001) C - Conversion I 0.00 -3,250,000 0
2019-07-23 2019-07-22 4 Sanofi Through its wholly-owned subsidiary, Aventis Inc. FULC Common Stock (par value $0.001) P - Purchase I 16.0000 93,750 1,500 558,035
2019-07-23 2019-07-22 4 Sanofi Through its wholly-owned subsidiary, Aventis Inc. FULC Common Stock (par value $0.001) C - Conversion I 464,285 464,285
2019-07-22 2019-07-22 4 Section 32 Fund 2, LP FULC Series B Preferred Stock C - Conversion D -3,250,000 0
2019-07-22 2019-07-22 4 Section 32 Fund 2, LP FULC Common Stock C - Conversion D 464,285 464,285
2019-07-22 2019-07-22 4 LEVIN MARK J By fund FULC Series A Preferred Stock C - Conversion I -39,166,667 0
2019-07-22 2019-07-22 4 LEVIN MARK J By fund FULC Common Stock P - Purchase I 16.0000 81,250 1,300 5,962,202
2019-07-22 2019-07-22 4 LEVIN MARK J By fund FULC Common Stock C - Conversion I 5,595,238 5,880,952
2019-07-22 2019-07-22 4 Casdin Capital, LLC FULC Series B Preferred Stock C - Conversion I -3,250,000 0
2019-07-22 2019-07-22 4 Casdin Capital, LLC FULC Common Stock P - Purchase I 14.4998 5,000 72 604,285
2019-07-22 2019-07-22 4 Casdin Capital, LLC FULC Common Stock P - Purchase I 14.4996 10,000 145 599,285
2019-07-22 2019-07-22 4 Casdin Capital, LLC FULC Common Stock P - Purchase I 16.0000 125,000 2,000 589,285
2019-07-22 2019-07-22 4 Casdin Capital, LLC FULC Common Stock C - Conversion I 464,285 464,285
2019-07-22 2019-07-22 4 6 Dimensions Capital, L.P. FULC Series B Preferred Stock C - Conversion D -3,087,500 0
2019-07-22 2019-07-22 4 6 Dimensions Capital, L.P. FULC Common Stock P - Purchase D 16.0000 118,750 1,900 559,821
2019-07-22 2019-07-22 4 6 Dimensions Capital, L.P. FULC Common Stock C - Conversion D 441,071 441,071
2019-07-22 2019-07-22 4 Third Rock Ventures III, L.P. FULC Series A Preferred Stock C - Conversion D 0 0
2019-07-22 2019-07-22 4 Third Rock Ventures III, L.P. FULC Series A Preferred Stock C - Conversion D -39,166,667 0
2019-07-22 2019-07-22 4 Third Rock Ventures III, L.P. FULC Common Stock P - Purchase D 16.0000 81,250 1,300 5,962,202
2019-07-22 2019-07-22 4 Third Rock Ventures III, L.P. FULC Common Stock C - Conversion D 5,595,238 5,880,952
2019-07-22 2019-07-22 4 Third Rock Ventures IV, L.P. FULC Series A Preferred Stock C - Conversion D -15,833,333 0
2019-07-22 2019-07-22 4 Third Rock Ventures IV, L.P. FULC Common Stock P - Purchase D 16.0000 81,250 1,300 2,343,154
2019-07-22 2019-07-22 4 Third Rock Ventures IV, L.P. FULC Common Stock C - Conversion D 2,261,904 2,261,904
2019-07-18 2019-07-18 4 Thomson Peter G. FULC Stock Option (right to buy) A - Award D 16.00 7,078 7,078
2019-07-18 2019-07-18 4 Stuart Bryan FULC Stock Option (right to buy) A - Award D 16.00 28,571 28,571
2019-07-18 2019-07-18 4 Cadavid Diego FULC Stock Option (right to buy) A - Award D 16.00 12,784 12,784
2019-07-18 2019-07-18 4 Gould Robert J FULC Stock Option (right to buy) A - Award D 16.00 107,142 107,142
2019-07-18 2019-07-18 4 Haviland Kate FULC Stock Option (right to buy) A - Award D 16.00 9,285 9,285
2019-07-18 2019-07-18 4 Ezekowitz Alan FULC Stock Option (right to buy) A - Award D 16.00 5,714 5,714
2019-07-18 2019-07-18 4 GERAGHTY JAMES A FULC Stock Option (right to buy) A - Award D 16.00 9,285 9,285
2019-07-18 2019-07-18 4 Collins James J. FULC Stock Option (right to buy) A - Award D 16.00 5,714 5,714
2019-07-18 2019-07-18 4 Wallace Owen B. FULC Stock Option (right to buy) A - Award D 16.00 44,493 44,493
2019-07-17 3 GERAGHTY JAMES A FULC Common Stock D 161,428
2019-07-17 3 GERAGHTY JAMES A FULC Common Stock D 161,428
2019-07-17 3 GERAGHTY JAMES A FULC Common Stock D 161,428
2019-07-17 3 Collins James J. FULC Common Stock D 47,142
2019-07-17 3 Collins James J. FULC Common Stock D 47,142
2019-07-17 3 Collins James J. FULC Common Stock D 47,142
2019-07-17 3 Wallace Owen B. FULC Common Stock D 254,176
2019-07-17 3 Wallace Owen B. FULC Common Stock D 254,176
2019-07-17 3 Wallace Owen B. FULC Common Stock D 254,176
2019-07-17 3 Gould Robert J FULC Common Stock D 1,114,690
2019-07-17 3 Gould Robert J FULC Common Stock D 1,114,690
2019-07-17 3 Gould Robert J FULC Common Stock D 1,114,690
2019-07-17 3 Thomson Peter G. FULC Common Stock D 77,142
2019-07-17 3 Thomson Peter G. FULC Common Stock D 77,142
2019-07-17 3 Thomson Peter G. FULC Common Stock D 77,142
2019-07-17 3 Ezekowitz Alan FULC Common Stock D 57,854
2019-07-17 3 Ezekowitz Alan FULC Common Stock D 57,854
2019-07-17 3 Ezekowitz Alan FULC Common Stock D 57,854
2019-07-17 3 Cadavid Diego FULC Common Stock D 142,142
2019-07-17 3 Cadavid Diego FULC Common Stock D 142,142
2019-07-17 3 Cadavid Diego FULC Common Stock D 142,142
2019-07-17 3 LEVIN MARK J FULC Common Stock I 571,428
2019-07-17 3 LEVIN MARK J FULC Common Stock I 571,428
2019-07-17 3 LEVIN MARK J FULC Common Stock I 571,428
2019-07-17 3 TEPPER ROBERT I FULC Common Stock I 571,428
2019-07-17 3 TEPPER ROBERT I FULC Common Stock I 571,428
2019-07-17 3 TEPPER ROBERT I FULC Common Stock I 571,428
2019-07-17 3 TEPPER ROBERT I FULC Common Stock I 571,428
2019-07-17 3 TEPPER ROBERT I FULC Common Stock I 571,428
2019-07-17 3 TEPPER ROBERT I FULC Common Stock I 571,428
2019-07-17 3 TEPPER ROBERT I FULC Common Stock I 571,428
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista